CA Patent

CA3216609C — Microcapsule compositions and methods

Assigned to 10X Genomics Inc · Expires 2024-05-14 · 2y expired

What this patent protects

This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For ex…

USPTO Abstract

This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For example, a device of this disclosure can achieve physical partitioning and discrete mixing of samples with unique molecular identifiers within a single unit in preparation for various analysis operations. The device may be useful in a variety of applications and most notably nucleic-acid- based sequencing, detection and quantification of gene expression and single- cell analysis.

Drugs covered by this patent

Patent Metadata

Patent number
CA3216609C
Jurisdiction
CA
Classification
Expires
2024-05-14
Drug substance claim
No
Drug product claim
No
Assignee
10X Genomics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.